ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628115 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628115; 2) Community: the network communities that were significantly associated with the response to NSC 628115; 3) Molecule: the relationships between components within communities and NSC 628115; 4) MDR: the compounds that were significantly associated with the NSC 628115.

NSC Compound Enrichment Correlation
NSC 670782 Null 0.000150163566228977 0.49100777
NSC 670961 Null 0.000150163566228977 0.58262973
NSC 682864 Null 0.000150163566228977 0.33014015
NSC 689449 Null 0.000150163566228977 0.5854789
NSC 698959 Null 0.000150163566228977 0.72509314
NSC 706192 Null 0.000150163566228977 0.49595543
NSC 711611 Null 0.000150163566228977 0.54879649
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.000150163566228977 0.52335981
NSC 736164 pyrazoline derivative 0.000150163566228977 0.32999272
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.000150163566228977 0.39141245
Total:180  Current:4    [First] [Prev] [Next] [Last]